Influence of Propylthiouracil and Methimazole Pre-treatment on the Outcome of Iodine-131 Therapy in Hyperthyroid Patients with Graves' Disease

被引：8
|
作者：
Shi, G-M [1 ]
Xu, Q. [2 ]
Zhu, C-Y [2 ]
Yang, Y-L [2 ]
机构：
[1] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Chemotherapy, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Nucl Med, Hangzhou 310003, Zhejiang, Peoples R China
来源：
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 2009年 / 37卷 / 02期
关键词：
GRAVES' DISEASE; HYPERTHYROIDISM; PROPYLTHIOURACIL; METHIMAZOLE; (131)I THERAPY; RADIOACTIVE IODINE THERAPY; RANDOMIZED CLINICAL-TRIAL; RADIOIODINE THERAPY; ANTITHYROID DRUGS; CURE RATES; EFFICACY;
D O I：
10.1177/147323000903700235
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
There is ongoing controversy about potential differences in the influence of the anti-thyroid drugs propylthiouracil (PTU) and methimazole (MMI) on radioiodine treatment of Graves' hyperthyroidism. This retrospective study investigated the influence of PTU and MMI pre-treatment, individually or sequentially, on the outcome of iodine-131 ((131)I) therapy in 199 patients with Graves' disease who had been treated with (131)I for the first time and followed up at 3 and 6 months after treatment. Pre-treatment with PTU, or sequential PTU and MMI pretreatment, increased the failure rate of (131)I therapy and reduced the rate of hypothyroidism. MMI pre-treatment alone had no significant influence on the results of (131)I therapy. Logistic regression analyses indicated that PTU pre-treatment and having a thyroid gland of > 60 g were both significantly related to (131)I therapy failure.
引用
收藏
页码：576 / 582
页数：7
相关论文
共 50 条
  • [41] Could effective iodine-131 half-life be extended by lithium carbonate in Graves' disease patients: Results from a retrospective analysis
    Gao, Xuemei
    Wu, Binbin
    Zhou, Qian
    Liu, Yan
    Wang, Ruihua
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (06): : 1711 - 1716
  • [42] Evaluation of osseous tissue response to minor oral surgical procedures in the first 9 months after radioactive iodine-131 therapy in adult female patients with Graves Disease
    Abd El-Ghany, A. M. A. A.
    Mohamed, M. N. F. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S169 - S169
  • [43] Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome
    Reinhardt, MJ
    Brink, I
    Joe, AY
    von Mallek, D
    Ezziddin, S
    Palmedo, H
    Krause, TM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (09) : 1118 - 1124
  • [44] Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome
    Michael J. Reinhardt
    Ingo Brink
    Alexius Y. Joe
    Dirk von Mallek
    Samer Ezziddin
    Holger Palmedo
    Thomas M. Krause
    European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29 : 1118 - 1124
  • [45] The influence of the delayed 131-iodine ablative therapy to the outcome of patients with diffentiated thyroid carcinomas
    Koutsioumpa, A
    Trivizaki, E
    Saranti, S
    Natsis, P
    Iordanidou, L
    Babali, V
    Pateniotis, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1208 - 1208
  • [46] Influence of smoking associated with stress on the outcome of radioiodine therapy in patients with Graves' disease
    Sekulic, V.
    Rajic, M.
    Vlajkovic, M.
    Ilic, S.
    Stevic, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S401 - S401
  • [47] Absolute quantification of thyroid uptake and volume using SPECT-CT in pre and post low dose iodine-131 therapy in patients with Grave's disease
    Nicolas, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S112 - S113
  • [48] Initial activity-related long-term outcome of iodine-131 treatment for thyroidectomy patients with differentiated thyroid carcinoma
    Hung, Mao-Chin
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2020, 23 (03): : 246 - 250
  • [49] Pre-treatment PSA velocity as a predictor of disease outcome following radical radiation therapy
    Palma, D.
    Tyldesley, S.
    Blood, P.
    Liu, M.
    Duncan, G.
    Morris, J.
    Pickles, T.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S36 - S36
  • [50] Iodine-131 Combined With Plasma Exchange Treatment in Graves' Hyperthyroidism Patients With Severe Liver Injury Whose Average Model for End-Stage Liver Disease Scores >20
    Zhu, Xin-Fang
    Ding, Rong-Rong
    Wang, Bing-Yao
    Yang, Yun-hui
    Ta, Fu-Xia
    Wang, Yuan
    Gao, Qing-Mei
    Zhang, Qi
    Xia, Rong
    Luo, Xing-Guang
    Wang, Xuan
    Zheng, Jian-Ming
    Zhu, Hui-Qing
    GASTRO HEP ADVANCES, 2025, 4 (04):
12345